IMMPF
Immupharma Plc

12
Loading...
Loading...
ImmuPharma Plc engages in the research, development, and commercialization of pharmaceutical products. It is focused on the development of drugs, primarily based on peptide therapeutics, to treat serious medical conditions such as autoimmune diseases. The firm's portfolio consists of four novel peptide therapy areas: autoimmunity, metabolism, cancer and anti-infectives. Its drug Lupuzor, is a potential treatment for the autoimmune chronic inflammatory disease lupus. The company was founded by Richard Warr and Dimitri F. Dimitriou in 1999 and is headquartered in London, the United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Immupharma Plc?
What is the 52-week high for Immupharma Plc?
What is the 52-week low for Immupharma Plc?
What is Immupharma Plc stock price today?
What was Immupharma Plc stock price yesterday?
What is the PE ratio of Immupharma Plc?
What is the Price-to-Book ratio of Immupharma Plc?
What is the 50-day moving average of Immupharma Plc?

Latest IMMPF News

View
No IMMPF news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.